Detalhe da pesquisa
1.
Is there any diagnostic value of serum protease-activated receptor-1 (PAR1) levels on determination of epithelial ovarian carcinoma?
Tumour Biol
; 35(5): 4323-9, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24390664
2.
EXPRESSION OF ALU REPEAT IN BLOOD PLASMA OF PATIENTS WITH BREAST CANCER DURING NEOADJUVANT CHEMOTHERAPY: AN EXPLORATORY STUDY.
Exp Oncol
; 45(1): 120-124, 2023 06 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37417275
3.
The access rate to diagnosis and treatment modalities in breast cancer patients in Turkey; multicenter observational study.
J BUON
; 16(4): 664-71, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22331719
4.
Mammaglobin and maspin transcripts in blood may reflect disease progression and the effect of therapy in breast cancer.
Genet Mol Res
; 9(1): 97-106, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20092039
5.
MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer.
Ann Oncol
; 19(4): 669-74, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18006896
6.
The role of postoperative radiotherapy in node negative breast cancer patients with pT3-T4 disease.
Eur J Surg Oncol
; 33(3): 285-93, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17145158
7.
Value of glutathion-S transferase pi as a prognostic factor in epithelial ovarian carcinoma.
Eur J Gynaecol Oncol
; 26(1): 90-4, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15755010
8.
Bcl-2 gene rearrangements and apoptosis rates in patients with non-Hodgkin's lymphoma during chemotherapy.
Clin Biochem
; 32(1): 45-9, 1999 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-10074891
9.
Stevens-Johnson syndrome in a patient receiving anticonvulsant therapy during cranial irradiation.
Am J Clin Oncol
; 24(4): 347-50, 2001 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-11474258
10.
Angiogenesis and p53 protein expression in breast cancer: prognostic roles and interrelationships.
Am J Clin Oncol
; 23(6): 546-53, 2000 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-11202793
11.
Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
J Exp Clin Cancer Res
; 19(4): 477-81, 2000 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-11277326
12.
Efficacy of cisplatin and cyclophosphamide combination for recurrent and metastatic carcinoma of the uterine cervix.
Eur J Gynaecol Oncol
; 24(3-4): 323-6, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12807249
13.
Intraperitoneal cisplatin--mitoxantrone in ovarian cancer patients with minimal residual disease.
Eur J Gynaecol Oncol
; 18(1): 71-5, 1997.
Artigo
em Inglês
| MEDLINE | ID: mdl-9061330
14.
Intraperitoneal cisplatin-mitoxantrone and intravenous ifosfamide combination as first-line treatment of ovarian cancer.
Eur J Gynaecol Oncol
; 19(3): 265-70, 1998.
Artigo
em Inglês
| MEDLINE | ID: mdl-9641228
15.
Catheter complications associated with intraperitoneal chemotherapy.
Eur J Gynaecol Oncol
; 19(3): 275-9, 1998.
Artigo
em Inglês
| MEDLINE | ID: mdl-9641230
16.
The role of chemotherapy in malignant mixed mullerian tumors of the female genital tract.
Eur J Gynaecol Oncol
; 22(6): 469-72, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11874086
17.
Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer.
Eur J Gynaecol Oncol
; 21(6): 599-602, 2000.
Artigo
em Inglês
| MEDLINE | ID: mdl-11214619
18.
The efficacy of combination chemotherapy including intraperitoneal cisplatinum and mitoxantrone with intravenous ifosfamide in patients with FIGO stage I C ovarian carcinoma.
Eur J Gynaecol Oncol
; 22(1): 70-3, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11321501
19.
Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: a multicentric Turkish Oncology Group (TOG) trial.
Breast
; 22(5): 628-33, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23954396
20.
A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma.
Gynecol Oncol
; 96(2): 374-80, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15661224